Ira Mellman
From Wikipedia, the free encyclopedia
Ira Mellman | |
|---|---|
| Born | Ira Seth Mellman |
| Alma mater | Oberlin College Yale University Rockefeller University |
| Known for | endosomes |
| Awards | Member of the National Academy of Sciences EMBO Member |
| Scientific career | |
| Fields | Cell biology |
| Institutions | Parker Institute for Cancer Immunotherapy Genentech University of California, San Francisco |
| Doctoral advisor | Leon E. Rosenberg |
| Other academic advisors | Ralph Steinman |
| Doctoral students | Shannon Turley[1] |
Ira Seth Mellman is an American cell biologist who discovered endosomes.[2][3][4] He is currently the president of research at the Parker Institute for Cancer Immunotherapy (PICI). He served as Vice President of Cancer Immunology at Genentech in South San Francisco, California where he led the development of several cancer therapies including atezolizumab and mosunetuzumab.[3]
Mellman grew up in New York, where he lived until he enrolled at Oberlin College in Oberlin, Ohio. While in college he maintained an interest in music but focused on the rapidly expanding field of cell biology. Working with David Miller, he began to study Chlamydomonas and found that a significant amount of the cell wall consisted of extensin.[5] After leaving Oberlin, he enrolled in the graduate program at the University of California, Berkeley, but later transferred to Yale University to switch to research more applicable to people. At Yale, he studied the genetics behind vitamin B12 metabolism under the guidance of geneticist Leon E. Rosenberg. [3]
